Schwartz, G. G., Leiter, L. A., Ballantyne, C. M., Barter, P. J., Black, D. M., Kallend, D., . . . Kittelson, J. (2020). Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease. Diabetes Care.
Chicago Style aipamenaSchwartz, Gregory G., et al. "Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease." Diabetes Care 2020.
MLA aipamenaSchwartz, Gregory G., et al. "Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease." Diabetes Care 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.